S. Saito

发表

Ela2 Mutations and Clinical Manifestations in Familial Congenital Neutropenia

K. Koike, Masao Kobayashi, K. Sakashita, 2009, Journal of pediatric hematology/oncology.

Risk factors for diabetes mellitus and impaired glucose tolerance following allogeneic hematopoietic stem cell transplantation in pediatric patients with hematological malignancies

K. Koike, Y. Nakazawa, K. Sakashita, 2014, International Journal of Hematology.

Enhanced Expression of Anti-CD19 Chimeric Antigen Receptor in piggyBac Transposon-Engineered T Cells

C. Rooney, Y. Okuno, Y. Nakazawa, 2017, Molecular therapy. Methods & clinical development.

A lymphodepleted non‐human primate model for the assessment of acute on‐target and off‐tumor toxicity of human chimeric antigen receptor‐T cells

H. Kubo, Y. Nakazawa, S. Yagyu, 2021, Clinical & translational immunology.

Critical Illness Polyneuropathy and Myopathy Caused by Bacillus Cereus Sepsis in Acute Lymphoblastic Leukemia

K. Koike, Y. Nakazawa, K. Sakashita, 2012, Journal of pediatric hematology/oncology.

Retrospective analysis of risk factors for development of liver dysfunction in transient leukemia of Down syndrome

K. Koike, Tomohiko Nakamura, K. Sakashita, 2011, Leukemia & lymphoma.

Successful cord blood transplantation after repeated transfusions of unmobilized neutrophils in addition to antifungal treatment in an infant with chronic granulomatous disease complicated by invasive pulmonary aspergillosis

K. Koike, Y. Nakazawa, K. Agematsu, 2014, Transfusion.

Bilateral perisylvian polymicrogyria, periventricular nodular heterotopia, and left ventricular noncompaction in a girl with 10.5–11.1 Mb terminal deletion of 1p36

Y. Fukushima, N. Matsumoto, K. Koike, 2008, American journal of medical genetics. Part A.

Mutated GM‐CSF‐based CAR‐T cells targeting CD116/CD131 complexes exhibit enhanced anti‐tumor effects against acute myeloid leukaemia

Y. Nakazawa, Aiko Hasegawa, K. Matsuda, 2020, Clinical & translational immunology.

Disappearance of minimal residual disease after the early withdrawal of immunosuppressants in a patient with juvenile myelomonocytic leukemia

T. Kamijo, K. Koike, Y. Nakazawa, 2011, Pediatric Blood & Cancer.

Engraftment syndrome, but not acute GVHD, younger age, CYP3A5 or MDR1 polymorphisms, increases tacrolimus clearance in pediatric hematopoietic SCT

K. Koike, Y. Nakazawa, Y. Katsuyama, 2011, Bone Marrow Transplantation.

Feasibility and Immune Response of WT1 Peptide Vaccination in Combination with OK-432 for Paediatric Solid Tumors.

H. Sugiyama, Y. Nakazawa, K. Sano, 2018, Anticancer research.

Genetic analysis of TP53 in childhood myelodysplastic syndrome and juvenile myelomonocytic leukemia.

K. Koike, Y. Nakazawa, K. Matsuda, 2011, Leukemia research.

Food allergy after cord blood transplantation in children

K. Koike, Y. Nakazawa, K. Sakashita, 2012, British journal of haematology.

Investigation of risk factors associated with erythrocyte engraftment after ABO‐incompatible hematopoietic stem cell transplantation

Y. Nakazawa, T. Shigemura, S. Saito, 2021, Clinical transplantation.

Polymyxin‐direct hemoperfusion for sepsis‐induced multiple organ failure

K. Koike, Y. Nakazawa, K. Sakashita, 2010, Pediatric blood & cancer.

Replaced platelet concentrates containing a new additive solution, M‐sol: safety and efficacy for pediatric patients

K. Koike, Y. Nakazawa, H. Azuma, 2013, Transfusion.

Non-viral inducible caspase 9 mRNA delivery using lipid nanoparticles against breast cancer: An in vitro study.

Y. Nakazawa, S. Yagyu, S. Saito, 2022, Biochemical and biophysical research communications.

Prophylactic piperacillin administration in pediatric patients with solid tumors following different intensities of chemotherapy

Tomohiko Nakamura, K. Sakashita, S. Saito, 2019, Pediatrics international : official journal of the Japan Pediatric Society.

CD30+ anaplastic large cell lymphoma complicated by pyoderma gangrenosum with increased levels of serum cytokines

K. Koike, W. Hosoda, K. Sakashita, 2006, European journal of haematology.

Ovarian function after allogeneic hematopoietic stem cell transplantation in children and young adults given 8‐Gy total body irradiation‐based reduced‐toxicity myeloablative conditioning

K. Koike, Y. Nakazawa, K. Sakashita, 2019, Pediatric transplantation.

In vitro expansion of CD34+CD38− cells under stimulation with hematopoietic growth factors on AGM-S3 cells in juvenile myelomonocytic leukemia

Y. Nakazawa, T. Nakahata, T. Heike, 2014, Leukemia.

Myeloid progenitors with PTPN11 and nonRAS pathway gene mutations are refractory to treatment with 6-mercaptopurine in juvenile myelomonocytic leukemia

Y. Nakazawa, K. Matsuda, T. Honda, 2014, Leukemia.

Intrathecal donor lymphocyte infusion for isolated leukemia relapse in the central nervous system following allogeneic stem cell transplantation: a case report and literature review

K. Koike, Y. Nakazawa, S. Shimodaira, 2015, International Journal of Hematology.

Safety, tolerability, and feasibility of antifungal prophylaxis with micafungin at 2 mg/kg daily in pediatric patients undergoing allogeneic hematopoietic stem cell transplantation

K. Koike, Y. Nakazawa, Y. Katsuyama, 2014, Infection.

Comparative analysis of graft-versus-host disease prophylaxis with tacrolimus in combination with methylprednisolone or methotrexate after umbilical cord blood transplantation

Y. Nakazawa, K. Sakashita, T. Shigemura, 2020, International Journal of Hematology.

T. Honda, M. Sugano, Takehisa Matsumoto, 2016, Japanese journal of infectious diseases.

Application of allele-specific quantitative PCR using genomic DNA to monitor minimal residual disease based on mutant gene levels following allogeneic hematopoietic stem cell transplantation in patients with hematological malignancies: comparison of mutant levels with autologous DNA percentage by sh

K. Matsuda, T. Honda, M. Sugano, 2012, Clinica chimica acta; international journal of clinical chemistry.

Increasing Risk of Disturbed Root Development in Permanent Teeth in Childhood Cancer Survivors Undergoing Cancer Treatment at Older Age

H. Kurita, K. Koike, Y. Nakazawa, 2017, Journal of pediatric hematology/oncology.

Clinical and laboratory outcomes after umbilical cord blood transplantation in a patient with mucolipidosis II alpha/beta

E. Nanba, K. Koike, Y. Nakazawa, 2016, American journal of medical genetics. Part A.

Myeloid progenitors with PTPN 11 and non-RAS pathway gene mutations are 1 refractory to treatment with 6-mercaptopurine in juvenile myelomonocytic 2 leukemia 3 4

Koichi, K. Koike, Y. Nakazawa, 2014 .

Transfusion outcome for volume- and plasma-reduced platelet concentrates for pediatric patients.

Y. Nakazawa, K. Sakashita, S. Saito, 2020, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Relationship between allergic transfusion reactions and allergic predisposition among pediatric patients with hematological/oncological disease

Y. Nakazawa, N. Ishimine, K. Sakashita, 2022, Transfusion.

Basophil activation test for allergic and febrile non‐haemolytic transfusion reactions among paediatric patients with haematological or oncological disease

Y. Nakazawa, K. Sakashita, S. Saito, 2022, Vox Sanguinis.

Nonocclusive Mesenteric Ischemia after Chemotherapy in an Adolescent Patient with a History of Three Allogeneic Hematopoietic Stem Cell Transplantations for Acute Lymphoblastic Leukemia.

K. Koike, Y. Nakazawa, S. Ishizone, 2017, Pediatrics and neonatology.

Usefulness of allogeneic hematopoietic stem cell transplantation in first complete remission for pediatric blastic plasmacytoid dendritic cell neoplasm with skin involvement: A case report and review of literature

K. Koike, Y. Nakazawa, K. Sakashita, 2013, Pediatric blood & cancer.

Complete measurable residual disease response after combination chemotherapy with AML-type and ALL-type regimens in pediatric B/myeloid acute bilineal leukemia

K. Koike, Y. Nakazawa, K. Matsuda, 2019, Leukemia & lymphoma.

Reduced-toxicity myeloablative conditioning consisting of 8-Gy total body irradiation, cyclophosphamide and fludarabine for pediatric hematological malignancies

K. Koike, Y. Nakazawa, K. Sakashita, 2014, Scientific Reports.

Immature Platelet Fraction and Its Kinetics in Neonates

Y. Nakazawa, F. Ishida, K. Sakashita, 2022, Journal of pediatric hematology/oncology.

GATA2 and secondary mutations in familial myelodysplastic syndromes and pediatric myeloid malignancies

S. Miyano, Y. Shiraishi, K. Chiba, 2015, Haematologica.

Factors affecting day-to-day variations in tacrolimus concentration among children and young adults undergoing allogeneic hematopoietic stem cell transplantation.

Y. Nakazawa, S. Saito, K. Hirabayashi, 2023, Transplantation and cellular therapy.

Successful ganciclovir therapy in a patient with human herpesvirus-6 encephalitis after unrelated cord blood transplantation: usefulness of longitudinal measurements of viral load in cerebrospinal fluid

K. Koike, Y. Nakazawa, Y. Katsuyama, 2013, Infection.

Impact of acute kidney injury on overall survival in children and young adults undergoing allogeneic hematopoietic stem cell transplantation

Y. Nakazawa, S. Saito, K. Hirabayashi, 2021, Pediatric blood & cancer.

Early-onset inflammatory bowel disease caused by mutations in the X-linked gene IL2RG.

Y. Nakazawa, K. Agematsu, T. Uehara, 2020, Journal of investigational allergology & clinical immunology.

Anti-leukemic potency of piggyBac-mediated CD19-specific T cells against refractory Philadelphia chromosome-positive acute lymphoblastic leukemia.

C. Rooney, K. Koike, Y. Nakazawa, 2014, Cytotherapy.

Assessment of kidney function using inulin‐based and estimated glomerular filtration rates before and after allogeneic hematopoietic stem cell transplantation in pediatric patients

Y. Nakazawa, S. Saito, K. Hirabayashi, 2020, Pediatric blood & cancer.

Autologous non‐human primate model for safety assessment of piggyBac transposon‐mediated chimeric antigen receptor T cells on granulocyte–macrophage colony‐stimulating factor receptor

Y. Nakazawa, Aiko Hasegawa, S. Yagyu, 2020, Clinical & translational immunology.

Proton beam therapy for adolescent primary central nervous system lymphoma with residual tumor after intensive chemotherapy: a case report.

Y. Nakazawa, H. Masaki, S. Saito, 2019, Practical radiation oncology.

Serial monitoring of Mucorales DNA load in serum samples of a patient with disseminated mucormycosis after allogeneic bone marrow transplantation

K. Koike, Y. Nakazawa, K. Matsuda, 2014, International Journal of Hematology.

Evaluation of Mucorales DNA load in cerebrospinal fluid in a patient with possible cerebral mucormycosis treated with intravenous liposomal amphotericin B.

K. Koike, Y. Nakazawa, K. Matsuda, 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

Successful treatment for West syndrome with severe combined immunodeficiency

K. Koike, Y. Nakazawa, K. Agematsu, 2015, Brain and Development.

Long-term survival after nonintensive chemotherapy in some juvenile myelomonocytic leukemia patients with CBL mutations, and the possible presence of healthy persons with the mutations.

K. Koike, Y. Nakazawa, T. Nakahata, 2010, Blood.

Safety and tolerability of allogeneic dendritic cell vaccination with induction of Wilms tumor 1-specific T cells in a pediatric donor and pediatric patient with relapsed leukemia: a case report and review of the literature.

Takashi Kurata, Masato Okamoto, Shoji Saito, 2015, Cytotherapy.

Loss of Mismatched HLA on the Leukemic Blasts of Patients With Relapsed Lymphoid Malignancies Following Bone Marrow Transplantation From Related Donors With HLA Class II Mismatches in the Graft Versus Host Direction

K. Koike, Y. Nakazawa, K. Matsuda, 2016, Pediatric blood & cancer.

Increased pretransplant QT dispersion as a risk factor for the development of cardiac complications during and after preparative conditioning for pediatric allogeneic hematopoietic stem cell transplantation

K. Koike, Y. Nakazawa, K. Sakashita, 2010, Pediatric transplantation.

Delayed methotrexate clearance and acute kidney injury after high‐dose methotrexate chemotherapy concurrent with dasatinib in a patient with relapsed Philadelphia chromosome‐positive acute lymphoblastic leukemia: A case report

Y. Nakazawa, K. Sakashita, T. Shigemura, 2020, Pediatric Blood & Cancer.

Thyroid tumor surveillance using ultrasound in childhood cancer survivors

Y. Nakazawa, S. Saito, Miyuki Tanaka, 2020, Pediatrics international : official journal of the Japan Pediatric Society.

Radiation necrosis following proton therapy successfully treated by low‐dose bevacizumab in a patient with relapsed anaplastic ependymoma

S. Yomo, K. Sakashita, S. Saito, 2018, Pediatric blood & cancer.

Skin and soft tissue infections in adolescent chronic myeloid leukemia under dasatinib treatment

Y. Nakazawa, A. Minagawa, S. Saito, 2022, Pediatric blood & cancer.

Evaluation of Mucorales DNA load in cerebrospinal fluid in a patient with possible cerebral mucormycosis treated with intravenous liposomal amphotericin B.

K. Koike, Y. Nakazawa, K. Matsuda, 2014, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.